Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,892 | 351 | 99.0% |
| Education | $39.46 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $467.72 | 35 | $0 (2019) |
| GlaxoSmithKline, LLC. | $465.57 | 56 | $0 (2019) |
| PFIZER INC. | $436.75 | 67 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $378.27 | 19 | $0 (2018) |
| Novo Nordisk Inc | $250.79 | 28 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $207.77 | 16 | $0 (2018) |
| Amgen Inc. | $204.67 | 13 | $0 (2019) |
| Allergan Inc. | $203.35 | 19 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $186.17 | 12 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $153.00 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.04 | 1 | PFIZER INC. ($23.04) |
| 2019 | $760.92 | 70 | PFIZER INC. ($160.44) |
| 2018 | $1,511 | 144 | GlaxoSmithKline, LLC. ($259.94) |
| 2017 | $1,636 | 140 | SANOFI-AVENTIS U.S. LLC ($178.11) |
All Payment Transactions
355 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2023 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 12/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/14/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/03/2019 | PFIZER INC. | CELEBREX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: INFLAMMATION;ONCOLOGY;PAIN | ||||||
| 09/25/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: DIABETES | ||||||
| 09/19/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Bone Health | ||||||
| 09/12/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/05/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/03/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/22/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.04 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DIABETES | ||||||
| 08/09/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.97 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/12/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/01/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/28/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/20/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 90 | $29,920 | $6,017 |
| 2022 | 9 | 273 | 349 | $64,526 | $14,571 |
| 2021 | 8 | 162 | 232 | $65,647 | $13,807 |
| 2020 | 10 | 217 | 332 | $81,454 | $17,784 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 46 | $13,708 | $2,548 | 18.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 24 | $10,272 | $2,198 | 21.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 19 | 20 | $5,940 | $1,270 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 96 | $27,744 | $5,202 | 18.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 18 | 43 | $11,653 | $2,245 | 19.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 54 | 54 | $2,160 | $2,115 | 97.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 17 | $9,112 | $1,693 | 18.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 29 | 29 | $8,352 | $1,538 | 18.4% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 16 | 16 | $4,624 | $909.61 | 19.7% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 22 | 22 | $880.00 | $867.74 | 98.6% |
| 91312 | Coronavirus vaccine 13 | Office | 2022 | 51 | 51 | $0.51 | $0.51 | 100.0% |
| 91305 | Sarscov2 vac 30 mcg trs-sucr | Office | 2022 | 21 | 21 | $0.21 | $0.21 | 100.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 65 | $18,200 | $3,686 | 20.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 20 | 37 | $9,703 | $2,032 | 20.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $9,365 | $2,021 | 21.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 32 | 33 | $9,224 | $1,952 | 21.2% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 15 | 15 | $7,429 | $1,570 | 21.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 30 | $4,568 | $974.76 | 21.3% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $3,637 | $810.52 | 22.3% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 12 | 21 | $3,523 | $761.04 | 21.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 40 | 81 | $22,012 | $4,697 | 21.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 26 | 50 | $12,725 | $2,870 | 22.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 38 | 41 | $11,121 | $2,460 | 22.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 15 | $7,575 | $1,549 | 20.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 27 | 46 | $6,797 | $1,392 | 20.5% |
About Dr. Mark Parsons, MD
Dr. Mark Parsons, MD is a Family Medicine healthcare provider based in Colfax, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992785778.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Parsons, MD has received a total of $3,931 in payments from pharmaceutical and medical device companies, with $23.04 received in 2023. These payments were reported across 355 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,892).
As a Medicare-enrolled provider, Parsons has provided services to 709 Medicare beneficiaries, totaling 1,003 services with total Medicare billing of $52,179. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Colfax, WA
- Active Since 01/18/2006
- Last Updated 10/14/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992785778
Products in Payments
- XARELTO (Drug) $308.66
- FARXIGA (Drug) $296.22
- LYRICA (Drug) $191.87
- CHANTIX (Drug) $182.95
- INVOKANA (Drug) $153.04
- Amitiza (Drug) $143.91
- ADVAIR (Drug) $140.58
- ENTRESTO (Drug) $117.45
- Prolia (Biological) $113.24
- Ozempic (Drug) $111.38
- BREO (Drug) $110.14
- ELIQUIS (Drug) $107.46
- JANUVIA (Drug) $99.51
- TOUJEO (Drug) $97.41
- Victoza (Drug) $95.53
- SOLIQUA (Drug) $92.35
- JARDIANCE (Drug) $86.79
- ANORO (Drug) $85.06
- EUFLEXXA (Device) $84.26
- TRULICITY (Drug) $72.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Colfax
Dr. William Mellor, M.d, M.D
Family Medicine — Payments: $3,737
Govind Singh, M.d, M.D
Family Medicine — Payments: $2,966
Gary Candelaria, D.o, D.O
Family Medicine — Payments: $757.70
Anthony Lundberg, Do, DO
Family Medicine — Payments: $486.84
Sarah Fielding, Md, MD
Family Medicine — Payments: $125.78
Dr. Brent Conrad, Md, MD
Family Medicine — Payments: $42.37